313 related articles for article (PubMed ID: 29104012)
21. Angiopoietin-like protein 3 markedly enhanced in the hyperlipidemia related proteinuria.
Gao X; Suo Y; Zhang M; Wang Y; Gao X; Bing Q; Liu Q
Lipids Health Dis; 2019 May; 18(1):116. PubMed ID: 31103046
[TBL] [Abstract][Full Text] [Related]
22. Inactivation of ANGPTL3 reduces hepatic VLDL-triglyceride secretion.
Wang Y; Gusarova V; Banfi S; Gromada J; Cohen JC; Hobbs HH
J Lipid Res; 2015 Jul; 56(7):1296-307. PubMed ID: 25954050
[TBL] [Abstract][Full Text] [Related]
23. Comparison of angiopoietin-like protein 3 and 4 reveals structural and mechanistic similarities.
Gunn KH; Gutgsell AR; Xu Y; Johnson CV; Liu J; Neher SB
J Biol Chem; 2021; 296():100312. PubMed ID: 33482195
[TBL] [Abstract][Full Text] [Related]
24. Angiopoietin-like protein 3 inhibits lipoprotein lipase activity through enhancing its cleavage by proprotein convertases.
Liu J; Afroza H; Rader DJ; Jin W
J Biol Chem; 2010 Sep; 285(36):27561-70. PubMed ID: 20581395
[TBL] [Abstract][Full Text] [Related]
25. A decreased expression of angiopoietin-like 3 is protective against atherosclerosis in apoE-deficient mice.
Ando Y; Shimizugawa T; Takeshita S; Ono M; Shimamura M; Koishi R; Furukawa H
J Lipid Res; 2003 Jun; 44(6):1216-23. PubMed ID: 12671033
[TBL] [Abstract][Full Text] [Related]
26. Comparison of the effect of post-heparin and pre-heparin lipoprotein lipase and hepatic triglyceride lipase on remnant lipoprotein metabolism.
Shirakawa T; Nakajima K; Shimomura Y; Kobayashi J; Stanhope K; Havel P; Machida T; Sumino H; Murakami M
Clin Chim Acta; 2015 Feb; 440():193-200. PubMed ID: 25239670
[TBL] [Abstract][Full Text] [Related]
27. Angiopoietin-like 3 in lipoprotein metabolism.
Kersten S
Nat Rev Endocrinol; 2017 Dec; 13(12):731-739. PubMed ID: 28984319
[TBL] [Abstract][Full Text] [Related]
28. ANGPTL3 decreases very low density lipoprotein triglyceride clearance by inhibition of lipoprotein lipase.
Shimizugawa T; Ono M; Shimamura M; Yoshida K; Ando Y; Koishi R; Ueda K; Inaba T; Minekura H; Kohama T; Furukawa H
J Biol Chem; 2002 Sep; 277(37):33742-8. PubMed ID: 12097324
[TBL] [Abstract][Full Text] [Related]
29. Association of circulating ANGPTL 3, 4, and 8 levels with medical status in a population undergoing routine medical checkups: A cross-sectional study.
Morinaga J; Zhao J; Endo M; Kadomatsu T; Miyata K; Sugizaki T; Okadome Y; Tian Z; Horiguchi H; Miyashita K; Maruyama N; Mukoyama M; Oike Y
PLoS One; 2018; 13(3):e0193731. PubMed ID: 29538435
[TBL] [Abstract][Full Text] [Related]
30. Regulation of triglyceride metabolism by Angiopoietin-like proteins.
Mattijssen F; Kersten S
Biochim Biophys Acta; 2012 May; 1821(5):782-9. PubMed ID: 22063269
[TBL] [Abstract][Full Text] [Related]
31. The Angiopoietin-Like Protein 3 and 8 Complex Interacts with Lipoprotein Lipase and Induces LPL Cleavage.
Jin N; Matter WF; Michael LF; Qian Y; Gheyi T; Cano L; Perez C; Lafuente C; Broughton HB; Espada A
ACS Chem Biol; 2021 Mar; 16(3):457-462. PubMed ID: 33656326
[TBL] [Abstract][Full Text] [Related]
32. The Citrus Flavonoid Nobiletin Downregulates Angiopoietin-like Protein 3 (ANGPTL3) Expression and Exhibits Lipid-Modulating Effects in Hepatic Cells and Adult Zebrafish Models.
Lin CY; Chen PY; Hsu HJ; Gao WY; Wu MJ; Yen JH
Int J Mol Sci; 2022 Oct; 23(20):. PubMed ID: 36293338
[TBL] [Abstract][Full Text] [Related]
33. Induced mutant mouse lines that express lipoprotein lipase in cardiac muscle, but not in skeletal muscle and adipose tissue, have normal plasma triglyceride and high-density lipoprotein-cholesterol levels.
Levak-Frank S; Hofmann W; Weinstock PH; Radner H; Sattler W; Breslow JL; Zechner R
Proc Natl Acad Sci U S A; 1999 Mar; 96(6):3165-70. PubMed ID: 10077655
[TBL] [Abstract][Full Text] [Related]
34. Circulating lipoprotein profiles are modulated differently by lipoprotein lipase in obese humans.
Goldberg IJ; Vanni-Reyes T; Ramakrishnan S; Holleran S; Ginsberg HN
J Cardiovasc Risk; 2000 Feb; 7(1):41-7. PubMed ID: 10785873
[TBL] [Abstract][Full Text] [Related]
35. Angiopoietin-like protein 8: a multifaceted protein instrumental in regulating triglyceride metabolism.
Wen Y; Chen YQ; Konrad RJ
Curr Opin Lipidol; 2024 Apr; 35(2):58-65. PubMed ID: 37962908
[TBL] [Abstract][Full Text] [Related]
36. Angiopoietin-like 3 inhibition of endothelial lipase is not modulated by angiopoietin-like 8.
Sylvers-Davie KL; Segura-Roman A; Salvi AM; Schache KJ; Davies BSJ
J Lipid Res; 2021; 62():100112. PubMed ID: 34461133
[TBL] [Abstract][Full Text] [Related]
37. An updated ANGPTL3-4-8 model as a mechanism of triglyceride partitioning between fat and oxidative tissues.
Zhang R; Zhang K
Prog Lipid Res; 2022 Jan; 85():101140. PubMed ID: 34793860
[TBL] [Abstract][Full Text] [Related]
38. The Lipid-Modulating Effect of Tangeretin on the Inhibition of Angiopoietin-like 3 (ANGPTL3) Gene Expression through Regulation of LXRα Activation in Hepatic Cells.
Chen PY; Chao TY; Hsu HJ; Wang CY; Lin CY; Gao WY; Wu MJ; Yen JH
Int J Mol Sci; 2021 Sep; 22(18):. PubMed ID: 34576019
[TBL] [Abstract][Full Text] [Related]
39. Effects of Angiopoietin-Like 3 on Triglyceride Regulation, Glucose Homeostasis, and Diabetes.
Christopoulou E; Elisaf M; Filippatos T
Dis Markers; 2019; 2019():6578327. PubMed ID: 30944669
[TBL] [Abstract][Full Text] [Related]
40. Angptl3-null mice show low plasma lipid concentrations by enhanced lipoprotein lipase activity.
Fujimoto K; Koishi R; Shimizugawa T; Ando Y
Exp Anim; 2006 Jan; 55(1):27-34. PubMed ID: 16508209
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
